BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9144728)

  • 1. Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a.
    Williams RO; Liu J; Koleng JJ
    Pharm Res; 1997 Apr; 14(4):438-43. PubMed ID: 9144728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI.
    Williams RO; Patel AM; Barron MK; Rogers TL
    Drug Dev Ind Pharm; 2001 May; 27(5):401-12. PubMed ID: 11448047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
    Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
    Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the metering chamber volume and actuator design on the aerodynamic particle size of a metered dose inhaler.
    Berry J; Heimbecher S; Hart JL; Sequeira J
    Drug Dev Ind Pharm; 2003 Sep; 29(8):865-76. PubMed ID: 14570307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of metered dose inhaler (MDI) formulations of ciclosporin.
    Marijani R; Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2007 Jan; 59(1):15-21. PubMed ID: 17227616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of temperature on the emitted dose of an oral metered dose inhaler.
    Williams RO; Barron MK
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1043-8. PubMed ID: 9876558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
    Abdou EM; Kandil SM; Morsi A; Sleem MW
    Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of co-grinding to formulate a model pMDI suspension.
    Williams RO; Repka MA; Barron MK
    Eur J Pharm Biopharm; 1999 Sep; 48(2):131-40. PubMed ID: 10469931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plume temperature emitted from metered dose inhalers.
    Brambilla G; Church T; Lewis D; Meakin B
    Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
    Gupta A; Stein SW; Myrdal PB
    J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the storage orientation on the aerodynamic particle size of a suspension metered dose inhaler containing propellant HFA-227.
    Berry J; Kline LC; Hart JL; Sequeira J
    Drug Dev Ind Pharm; 2003 Jul; 29(6):631-9. PubMed ID: 12889781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the valve lubricant on the aerodynamic particle size of a metered dose inhaler.
    Berry J; Kline L; Naini V; Chaudhry S; Hart J; Sequeira J
    Drug Dev Ind Pharm; 2004 Mar; 30(3):267-75. PubMed ID: 15109026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG; Millar AB; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
    Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
    Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of expansion chamber geometry on atomization and spray dispersion characters of a flashing mixture containing inerts. Part I. Numerical predictions and dual laser measurements.
    Ju D; Shrimpton J; Bowdrey M; Hearn A
    Int J Pharm; 2012 Aug; 432(1-2):23-31. PubMed ID: 22575753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.